leisure time -WSS

leisure time

author：knowledge 2025-09-27 16:48:21 - browse：6

Kuldeep Singh Rajput -- health tech coverage from STAT — Kuldeep Singh Rajput has left his role as CEO of Biofourmis. World Economic Forum

A month after conducting significant layoffs, Biofourmis is out a CEO: Kuldeep Singh Rajput, one of the company’s founders, has quietly stepped down from his role.

A Biofourmis spokesperson confirmed Rajput’s departure to STAT on Wednesday, and said that while the company hunts for a new CEO it will be helmed by a committee of executives overseen by new board member Ben Wanamaker, a partner at Biofourmis investor General Atlantic. The Boston-based company was valued at $1.3 billion following a $320 million Series D financing round which closed last summer and brought big names to Biofourmis: CVS Health was an investor, and Omar Ishrak, former CEO of Medtronic, and Sachin Jain, CEO of the SCAN Health Plan joined the board.

Founded in 2015, Biofourmis has been developing a dizzying array of tech-enabled care offerings, including home-based care services for hospitals, clinical trials support for biopharma companies, and a pipeline of software-based interventions for heart failure and other conditions.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Flint parents haunted by uncertainty, fears of lead poisoning

WSS

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

Traditional Chinese medicine benefits explored in new JAMA study

Florida officials tell state schools to teach AP Psychology 'in its entirety'

Readout Newsletter: What happened with Sarepta's Duchenne data

Traditional Chinese medicine benefits explored in new JAMA study

Biotech startup Celsius cuts 75% of staff ahead of first trial start

hotspot

leisure time

entertainment

Medicare proposal to cover medical devices draws a mixed reaction

2 officers injured in shooting in Orlando, police say

Duchenne breakthrough therapy leaves behind pioneering families

The FDA weighs the risks of candy

Bright Health sells Medicare Advantage business to Molina

Biotech startup Celsius cuts 75% of staff ahead of first trial start

Duchenne breakthrough therapy leaves behind pioneering families

Why Sanofi got shellacked over its spinoff

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

'Null' research findings aren't empty of meaning. Let's publish them

explore

Maker of FluMist seeks to allow at

Meta's Zuckerberg and Chan on track to put $50 billion into science

Maker of FluMist seeks to allow at

CDC recommends RSV monoclonal antibody for infants

Readout Newsletter: What happened with Sarepta's Duchenne data

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

leisure time

hotspot

knowledge

focus